OSTELUC Side Effects

5919680-4 | Platelet Count Decreased
on Sep 03, 2008 Female patient from JAPAN , 80 years of age, was treated with Osteluc (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased. Osteluc dosage: . During the same period patient was treated with MUCOSTA (View Mucosta Review and Mucosta Label ), BROTIZOLAM (View Brotizolam Review and Brotizolam Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5724005-3 | Stevens-johnson Syndrome
Patient was taking Osteluc (View Usage). Patient had the following side effects: stevens-johnson syndrome on Apr 29, 2008 from JAPAN Additional patient health information: Female patient , 31 years of age, was diagnosed with tenosynovitis and. Osteluc dosage: . Patient was hospitalized.

5708003-1 | Conjunctival Hyperaemia, Localised Oedema, Mucosal Erosion, Skin Exfoliation, Swelling Face
Adverse event was reported on Apr 09, 2008 by a Female patient taking Osteluc (View Usage) (Dosage: ) was diagnosed with tenosynovitis and. Location: JAPAN , 31 years of age, After Osteluc was administered, patient had the following side effects: conjunctival hyperaemia, localised oedema, mucosal erosion, skin exfoliation, swelling face. Patient was hospitalized.

5693806-2 | Conjunctival Hyperaemia, Localised Oedema, Mucosal Erosion, Skin Exfoliation, Swelling Face
on Mar 31, 2008 Female patient from JAPAN , 31 years of age, was diagnosed with tenosynovitis and was treated with Osteluc (View Usage). Patient experienced the following unwanted or unexpected effects: conjunctival hyperaemia, localised oedema, mucosal erosion, skin exfoliation, swelling face. Osteluc dosage: . Patient was hospitalized.


5691675-8 | Conjunctival Hyperaemia, Localised Oedema, Mucosal Erosion, Skin Exfoliation, Swelling Face
on Mar 27, 2008 Female patient from JAPAN , 31 years of age, was diagnosed with tenosynovitis and was treated with Osteluc (View Usage). Patient had the following side effects: conjunctival hyperaemia, localised oedema, mucosal erosion, skin exfoliation, swelling face. Osteluc dosage: . Patient was hospitalized.

5453673-9 | Acute Polyneuropathy, Erythema Multiforme
Patient was taking Osteluc (View Usage). After Osteluc was administered, patient had the following side effects: acute polyneuropathy, erythema multiforme on Sep 11, 2007 from JAPAN Additional patient health information: Female patient , 79 years of age, . Osteluc dosage: .

5350815-0 | Jaundice, Liver Disorder, Pruritus, Unevaluable Event
Adverse event was reported on May 29, 2007 by a Female patient taking Osteluc (View Usage) (Dosage: ) was diagnosed with arthralgia and. Location: JAPAN , weighting 119.0 lb, Patient experienced the following unwanted or unexpected effects: jaundice (What is jaundice?), liver disorder, pruritus, unevaluable event. Patient was hospitalized.

4728248-7 | Interstitial Lung Disease
on Jul 15, 2005 Female patient from JAPAN , 85 years of age, was diagnosed with osteoarthritis (What is osteoarthritis?) and was treated with Osteluc (View Usage). Patient had the following side effects: interstitial lung disease. Osteluc dosage: ^200 Or 400 Mg/day For A Total Of 200mg X 5^ Oral. During the same period patient was treated with GEFANIL (GEFARNATE) (View Gefanil (gefarnate) Review and Gefanil (gefarnate) Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ).